Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahide Taguchi

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2009
[The role and limitations of FDG-PET in head and neck cancer]Choichi Horiuchi, Mamoru Tsukuda, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|June 14, 2002
[Postoperative result for tympanic membrane perforation]Takahide Taguchi, Taro Nagahara, Hideki Matsuda, et al.
Oncology Reports|January 14, 2004
Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomasTakahide Taguchi, Yasumasa Kato, Yuh Baba, et al.
Cancer Science|June 3, 2011
Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activitiesNorio Kondo, Mamoru Tsukuda, Takahide Taguchi, et al.
Auris, Nasus, Larynx|July 18, 2008
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapyTakahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Plos One|February 19, 2015
Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT)Kenichiro Yabuki, Osamu Shiono, Masanori Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Anticancer Research|January 31, 2012
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinomaGoshi Nishimura, Hideki Matsuda, Takahide Taguchi, et al.
Oncology Letters|August 8, 2012
Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacyKouichi Nakazaki, Yasumasa Kato, Takahide Taguchi, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2009
[The role and limitations of FDG-PET in head and neck cancer]Choichi Horiuchi, Mamoru Tsukuda, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|June 14, 2002
[Postoperative result for tympanic membrane perforation]Takahide Taguchi, Taro Nagahara, Hideki Matsuda, et al.
Oncology Reports|January 14, 2004
Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomasTakahide Taguchi, Yasumasa Kato, Yuh Baba, et al.
Cancer Science|June 3, 2011
Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activitiesNorio Kondo, Mamoru Tsukuda, Takahide Taguchi, et al.
Auris, Nasus, Larynx|July 18, 2008
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapyTakahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Plos One|February 19, 2015
Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT)Kenichiro Yabuki, Osamu Shiono, Masanori Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Anticancer Research|January 31, 2012
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinomaGoshi Nishimura, Hideki Matsuda, Takahide Taguchi, et al.
Oncology Letters|August 8, 2012
Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacyKouichi Nakazaki, Yasumasa Kato, Takahide Taguchi, et al.
Pageof 7